The Association for Value-Based Cancer Care

Overview

The Association for Value-Based Cancer Care (AVBCC) is a 501(c)(6) nonprofit trade association that fosters collaboration and knowledge exchange among oncology stakeholders to optimize cancer care delivery. Founded in 2010 and headquartered in Cranbury, NJ, AVBCC convenes payers, providers, pharmaceutical companies, and policymakers around value, cost, quality, and access in oncology. The organization hosts an annual educational summit, publishes the Value-Based Cancer Care journal, and supports research through awards programs.

Services

• Annual Summit — Multi-day educational program featuring 90+ sessions, 300+ expert speakers, and panels on outcomes contracting, PBM reform, biosimilar adoption, and precision medicine
• Publications — Value-Based Cancer Care journal delivering research, policy analysis, and expert commentary
• Media & Education — Podcasts, educational videos, and expert articles on value-based oncology
• Awards — 40 Under 40 in Cancer recognizing emerging leaders; Young Investigator Awards supporting early-career oncology researchers
• Symposia — Global Cancer Research & Innovation Symposium bringing together international perspectives

Competitive Position

AVBCC is unique in its multidisciplinary model, convening the full oncology value chain rather than focusing on a single stakeholder group. The organization’s leadership includes chairs and co-chairs from Pfizer, AstraZeneca, McKesson, Optum Specialty Pharmacy, Texas Oncology, and Tempus AI, lending credibility to its educational programming. With 15+ years of focused programming on value-based cancer care, AVBCC has established itself as the authoritative voice on oncology payment and delivery reform.